We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA's Office of Generic Drugs (OGD) will hold discussions with industry "in the next few weeks or months" on the possibility of introducing user fees to speed the generic approval process, Gary Buehler, the office's director, disclosed at the 2006 Generic Pharmaceutical Association Fall Technical Conference Oct. 19.